TGF-β-Based Therapies for Treating Ocular Surface Disorders

Fernando T. Ogata,Sudhir Verma,Vivien J. Coulson-Thomas,Tarsis F. Gesteira
DOI: https://doi.org/10.3390/cells13131105
IF: 6
2024-06-26
Cells
Abstract:The cornea is continuously exposed to injuries, ranging from minor scratches to deep traumas. An effective healing mechanism is crucial for the cornea to restore its structure and function following major and minor insults. Transforming Growth Factor-Beta (TGF-β), a versatile signaling molecule that coordinates various cell responses, has a central role in corneal wound healing. Upon corneal injury, TGF-β is rapidly released into the extracellular environment, triggering cell migration and proliferation, the differentiation of keratocytes into myofibroblasts, and the initiation of the repair process. TGF-β-mediated processes are essential for wound closure; however, excessive levels of TGF-β can lead to fibrosis and scarring, causing impaired vision. Three primary isoforms of TGF-β exist—TGF-β1, TGF-β2, and TGF-β3. Although TGF-β isoforms share many structural and functional similarities, they present distinct roles in corneal regeneration, which adds an additional layer of complexity to understand the role of TGF-β in corneal wound healing. Further, aberrant TGF-β activity has been linked to various corneal pathologies, such as scarring and Peter's Anomaly. Thus, understanding the molecular and cellular mechanisms by which TGF-β1-3 regulate corneal wound healing will enable the development of potential therapeutic interventions targeting the key molecule in this process. Herein, we summarize the multifaceted roles of TGF-β in corneal wound healing, dissecting its mechanisms of action and interactions with other molecules, and outline its role in corneal pathogenesis.
cell biology
What problem does this paper attempt to address?
The problem that this paper attempts to solve is: how to utilize the potential of Transforming Growth Factor - Beta (TGF - β) in the treatment of ocular surface diseases, especially how to develop potential therapeutic interventions targeting key molecules by understanding the molecular and cellular mechanisms of TGF - β in the corneal wound - healing process. Specifically, the paper explores the following aspects: 1. **The role of TGF - β in corneal wound - healing**: The paper elaborately describes how TGF - β is rapidly released into the extracellular environment after the cornea is injured, triggering cell migration, proliferation, the trans - differentiation of keratinocytes into myofibroblasts and the initiation of the repair process. These processes are crucial for wound closure, but excessive TGF - β levels can lead to fibrosis and scar formation, thereby impairing vision. 2. **Different subtypes of TGF - β and their functions**: The paper discusses the different roles of the three main TGF - β subtypes (TGF - β1, TGF - β2 and TGF - β3) in corneal regeneration. Although these subtypes have many similarities in structure and function, their roles in corneal wound - healing are different, which increases the complexity of understanding the role of TGF - β in corneal wound - healing. 3. **Regulation of TGF - β signaling pathways**: The paper details the activation and regulation mechanisms of TGF - β signaling pathways, including the classical Smad - dependent pathway and the non - classical Smad - independent pathway. These pathways play important roles in cell migration, proliferation, differentiation and extracellular matrix production. 4. **Abnormal TGF - β signaling and corneal pathology**: The paper points out that abnormal TGF - β signaling is associated with multiple corneal diseases, such as scar formation and Peter’s Anomaly. By understanding these abnormal signaling pathways, new ideas can be provided for the development of targeted therapies. 5. **Treatment strategies**: The paper also discusses how to prevent excessive scar formation and improve the treatment outcomes of patients with corneal injuries by regulating TGF - β signaling pathways. Specific strategies include using monoclonal antibodies, small - molecule inhibitors and antisense oligonucleotides to interfere with TGF - β signaling pathways. In conclusion, this paper aims to provide a scientific basis for the development of new strategies for treating ocular surface diseases by in - depth research on the role of TGF - β in corneal wound - healing and its signaling pathways.